ArticleNature communications2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.
Madhuri Kalathur et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it